A detailed history of Arthur M. Cohen & Associates, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Arthur M. Cohen & Associates, LLC holds 5,483 shares of ABT stock, worth $701,440. This represents 0.11% of its overall portfolio holdings.

Number of Shares
5,483
Previous 5,483 -0.0%
Holding current value
$701,440
Previous $625,000 0.8%
% of portfolio
0.11%
Previous 0.11%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$100.07 - $118.13 $20,014 - $23,626
-200 Reduced 3.52%
5,483 $625,000
Q2 2024

Jul 29, 2024

SELL
$100.73 - $112.44 $14,605 - $16,303
-145 Reduced 2.49%
5,683 $590,000
Q1 2024

Apr 22, 2024

SELL
$109.52 - $120.96 $104,482 - $115,395
-954 Reduced 14.07%
5,828 $662,000
Q4 2023

Jan 10, 2024

BUY
$90.19 - $110.4 $14,340 - $17,553
159 Added 2.4%
6,782 $746,000
Q4 2022

Jan 17, 2023

BUY
$95.06 - $111.52 $3,802 - $4,460
40 Added 0.61%
6,623 $0
Q2 2021

Jul 27, 2021

BUY
$105.79 - $124.53 $56,068 - $66,000
530 Added 8.76%
6,583 $763,000
Q4 2019

Jan 10, 2020

SELL
$78.51 - $87.4 $54,957 - $61,180
-700 Reduced 10.37%
6,053 $525,000
Q3 2019

Nov 04, 2019

BUY
$81.84 - $88.74 $57,288 - $62,118
700 Added 11.56%
6,753 $565,000
Q2 2019

Jul 29, 2019

SELL
$72.88 - $85.0 $46,497 - $54,230
-638 Reduced 9.54%
6,053 $509,000
Q1 2019

May 07, 2019

BUY
$66.22 - $80.06 $46,354 - $56,042
700 Added 11.68%
6,691 $535,000
Q1 2018

Apr 23, 2018

SELL
$56.27 - $63.62 $39,389 - $44,534
-700 Reduced 10.46%
5,991 $349,000
Q4 2017

Mar 06, 2019

SELL
$53.68 - $57.47 $5,368 - $5,747
-100 Reduced 1.47%
6,691 $482,000
Q4 2017

Jan 26, 2018

BUY
$53.68 - $57.47 $21,472 - $22,988
400 Added 6.26%
6,791 $389,000
Q3 2014

Nov 08, 2017

BUY
N/A
6,391
6,391 $341,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $224B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Arthur M. Cohen & Associates, LLC Portfolio

Follow Arthur M. Cohen & Associates, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arthur M. Cohen & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Arthur M. Cohen & Associates, LLC with notifications on news.